Company / Gross Margin
Abbott Laboratories Gross Margin History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
17.9%
FY2018
5-year range
-
FY2016-FY2018
Trend
+32.1%
vs FY2017
Sector context
#93 of 96
Health Care
What the data says
Among 96 Health Care companies, Abbott Laboratories is in the bottom 3% for gross margin. Improved from 12.8% to 17.9% over the past 2 years.
Based on SEC 10-K filings.
17.9% in FY2018.
Improved from 12.8% to 17.9% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 96This company 17.9% Sector average 53.6%
▼
-66.5% below sector average
Key checks
Key Insights
- In FY2018, gross margin increased 32.1% year-over-year.
- Currently 35.7pp below the Health Care sector average.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | 17.9% | +32.1% |
| FY2017 | 13.6% | +5.6% |
| FY2016 | 12.8% | -5.0% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026